REG - Venture Life Group - Director Dealings
Today 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250703:nRSC5126Pa&default-theme=true
RNS Number : 5126P Venture Life Group PLC 03 July 2025
3 July 2025
VENTURE LIFE GROUP PLC
("Venture Life", "VLG" or the "Company")
Director Dealings
Venture Life (AIM: VLG), a leader in product innovation, development and
commercialisation within the global consumer healthcare sector, announces that
the following Directors of the Company purchased ordinary shares of 0.3 pence
each in the capital of the Company ("Ordnary Shares"):
Director Position Ordinary Shares Purchased Volume-weighted average price per Ordinary Share (pence) Resultant shareholding
Paul McGreevy Non-Executive Chairman 90,664 54.00 pence 897,049
(0.70%)
Jerry Randall Chief Executive Officer 50,000 59.20 pence 2,253,200
(1.76%)
Mark Adams Non-Exeuctive Director 44,989 55.57 pence 219,898
(0.17%)
Carl Dempsey Non-Executive Director 51,500 58.00 pence 200,000
(0.16%)
Further details of the dealings are provided below in accordance with the
Market Abuse Regulation.
For further information, please contact:
Venture Life Group PLC +44 (0) 1344 578004
Jerry Randall, Chief Executive Officer
Daniel Wells, Chief Financial Officer
Cavendish Capital Markets Limited (Nomad and Broker) +44 (0) 20 7720 0500
Stephen Keys / George Lawson (Corporate Finance)
Michael Johnson (Sales)
About Venture Life (www.venture-life.com (http://www.venture-life.com/) )
Venture Life is an international consumer self-care company focused on
commercialising products for the global self-care market. Headquartered in the
UK, the Group's product portfolio includes Balance Activ in the area of
women's intimate healthcare, Earol® supporting ENT care, Lift and Glucogel
product ranges for energy and glucose management and hypoglycaemia, plus the
Health and Her product range supporting the hormonal lifecycle.
The products, which are typically recommended by pharmacists or healthcare
practitioners, are available primarily through health & beauty stores,
pharmacies, grocery multiples and e-commerce channels and are sold globally.
In the UK, Ireland and the USA these are supplied direct by the company to
retailers, elsewhere they are supplied by the Group's international
distribution partners.
The Company makes the following disclosures in accordance with article 19(3)
of the Market Abuse Regulation:
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Paul McGreevy
2 Reason for the notification
a) Position/status Non-Executive Chairman
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Venture Life Group plc
b) LEI 213800S8CZUPLAB2KC70
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.3p each in Venture Life Group plc
Identification code
GB00BFPM8908
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price Volume
53.50 pence 54,180
54.52 pence 18,319
54.985 pence 18,165
d) Aggregated information 90,664 Ordinary Shares purchased at a volume-weighted average price of 54.00
pence
- Aggregated volume
- Price
e) Date of the transaction 30 June 2025
f) Place of the transaction London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
90,664 Ordinary Shares purchased at a volume-weighted average price of 54.00
pence
e)
Date of the transaction
30 June 2025
f)
Place of the transaction
London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Jerry Randall
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Venture Life Group plc
b) LEI 213800S8CZUPLAB2KC70
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.3p each in Venture Life Group plc
Identification code
GB00BFPM8908
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price Volume
59.199 pence 50,000
d) Aggregated information n/a - single transaction
- Aggregated volume
- Price
e) Date of the transaction 2 July 2025
f) Place of the transaction London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
n/a - single transaction
e)
Date of the transaction
2 July 2025
f)
Place of the transaction
London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Mark Adams
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Venture Life Group plc
b) LEI 213800S8CZUPLAB2KC70
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.3p each in Venture Life Group plc
Identification code
GB00BFPM8908
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price (pence) Volume
55.68 pence 26,939
55.40 pence 18,050
d) Aggregated information 44,989 Ordinary Shares purchased at a volume-weighted average price of 55.57
pence
- Aggregated volume
- Price
e) Date of the transaction 1 July 2025
f) Place of the transaction London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
44,989 Ordinary Shares purchased at a volume-weighted average price of 55.57
pence
e)
Date of the transaction
1 July 2025
f)
Place of the transaction
London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Carl Dempsey
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Venture Life Group plc
b) LEI 213800S8CZUPLAB2KC70
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.3p each in Venture Life Group plc
Identification code
GB00BFPM8908
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price (pence) Volume
58.00 pence 51,500
d) Aggregated information n/a - single transaction
- Aggregated volume
- Price
e) Date of the transaction 1 July 2025
f) Place of the transaction London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
n/a - single transaction
e)
Date of the transaction
1 July 2025
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLLLBEDLLBBERecent news on Venture Life
See all newsREG - Venture Life Group - Director Dealings
AnnouncementREG - Venture Life Group - Notice of General Meeting & Investor Presentation
AnnouncementREG - Venture Life Group - Holding(s) in Company
AnnouncementREG - Venture Life Group - Final Results for year ended 31 December 2024
AnnouncementREG - Venture Life Group - Result of AGM
Announcement